Subtype selective substrates for histone deacetylases

Journal of Medicinal Chemistry

Volumn 47, Issue 21, 2004, Pages 5235-5243

  Heltweg, Birgit ^a   Dequiedt, Franck ^b   Marshall, Brett L ^c   Brauch, Carsten ^a   Yoshida, Minoru ^d   Nishino, Norikazu ^e   Verdin, Eric ^c   Jung, Manfred ^a,f  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b Cellular and Molecular Biology Unit   (Belgium)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d RIKEN   (Japan)

^e KYUSHU INSTITUTE OF TECHNOLOGY   (Japan)

^f UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

[1 (4 METHYL 2 OXO 2H CHROMEN 7 YLCARBAMOYL) 5 (2,2,2 TRIFLUOROACETYLAMINO)PENTYL]CARBAMIC ACID BENZYL ESTER; [1 (4 METHYL 2 OXO 2H CHROMEN 7 YLCARBAMOYL) 5 ACETYLAMINOPENTYL]CARBAMIC ACID BENZYL ESTER; [1 (4 METHYL 2 OXO 2H CHROMEN 7 YLCARBAMOYL) 5 PROPIONYLAMINOPENTYL]CARBAMIC ACID BENZYL ESTER; [5 ACETYLAMINO 1 (2 OXO 4 METHYL 2H CHROMEN 7 YLCARBAMOYL)PENTYL]CARBAMIC ACID TERT BUTYL ESTER; [5 ACETYLAMINO 1 (2 OXO 4 TRIFLUOROMETHYL 2H CHROMEN 7 YLCARBAMOYL)PENTYL]CARBAMIC ACID TERT BUTYL ESTER; [5 ACETYLAMINO 1 (4 METHYL 2 OXO 2H CHROMEN 7 YLCARBAMOYL)PENTYL]CARBAMIC ACID 9H FLUOREN 9 YLMETHYL ESTER; CARBAMIC ACID DERIVATIVE; FUNCTIONAL GROUP; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; ISOENZYME; NICOTINAMIDE ADENINE DINUCLEOTIDE; RECOMBINANT ENZYME; SIRTUIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CHEMICAL MODIFICATION; CONTROLLED STUDY; DEACYLATION; DRUG SYNTHESIS; ENZYME SPECIFICITY; ENZYME SUBSTRATE; ENZYME SUBSTRATE COMPLEX; HELA CELL; HUMAN; HUMAN CELL; IC 50; NONHUMAN; RAT; STRUCTURE ACTIVITY RELATION;

ANIMALS; HELA CELLS; HISTONE DEACETYLASES; HUMANS; LIVER; LYSINE; RATS; RECOMBINANT PROTEINS; SIRTUINS; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTRATE SPECIFICITY;

EID: 4744370522     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0497592     Document Type: Article

References (35)

1. Grozinger, C. M.; Schreiber, S. L. Deacetylase enzymes: Biological functions and the use of small-molecule inhibitors. Chem. Biol. 2002, 9, 3-16.
2. Johnstone, R. W. Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nat. Rev. Drug Discovery 2002, 1, 287-299.
3. Gray, S. G.; Ekstrom, T. J. The human histone deacetylase family. Exp. Cell Res. 2001, 262, 75-83.
4. Finnin, M. S.; Donigian, J. R.; Cohen, A.; Richon, V. M.; Rifkind, R. A.; et al. Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature 1999, 401, 188-193.
5. Remiszewski, S. W.; Sambuccetti, L. C.; Atadja, P.; Bair, K. W.; Cornell, W. D.; et al. Inhibitors of human histone deacetylase: synthesis, enzyme and cellular activity of straight chain hydroxamates. J. Med. Chem. 2002, 45, 753-757.
6. Wegener, D.; Hildmann, C.; Riester, D.; Schwienhorst, A. Improved fluorogenic histone deacetylase assay for high-throughput screening applications. Anal. Biochem. 2003, 321, 202-208.
7. Wegener, D.; Wirsching, F.; Riester, D.; Schwienhorst, A. A fluorogenic histone deacetylase assay well suited for high-throughput activity screening. Chem. Biol. 2003, 10, 61-68.
8. Hoffmann, K.; Brosch, G.; Loidl, P.; Jung, M. Anonisotopicassay for histone deacetylase activity. Nucleic Acids Res. 1999, 27, 2057-2058.
9. Heltweg, B.; Jung, M. A micro plate reader based nonisotopic histone deacetylase activity assay. Anal. Biochem. 2002, 302, 175-183.
10. Heltweg, B.; Jung, M. A homogeneous nonisotopic assay for histone deacetylase activity. J. Biomol. Screening 2003, 8, 89-95.
11. +-dependent histone deacetylases. Anal. Biochem. 2003, 319, 42-48.
12. Rijkers, D. T. S.; Adams, H. P. H. M.; Hemker, H. C.; Tesser, G. I. A convenient synthesis of amino acidp-nitroanilides- synthons in the synthesis of protease substrates. Tetrahedron 1995, 51, 11235-11250.
13. Bernardi, L.; De Castiglione, R.; Fregnan, G. B.; Glässer, A. H. An experimental approach to long-lasting hypotensive eledoisin-like peptides. J. Pharm. Pharmacol. 1967, 19, 95-101.
14. Hoffmann, K.; Heltweg, B.; Jung, M. Improvement and validation of the fluorescence-based histone deacetylase assay using an internal standard. Arch. Pharm. Pharm. Med. Chem. 2001, 334, 248-252.
15. Jackson, M. D.; Schmidt, M. T.; Oppenheimer, N. J.; Denu, J. M. Mechanism of nicotinamide inhibition and transglycosidation by Sir2 histone/protein deacetylases. J. Biol. Chem. 2003, 278, 50985-50998.
16. Fischle, W.; Dequiedt, F.; Pillion, M.; Hendzel, M. J.; Voelter, W.; et al. Human HDAC7 histone deacetylase activity is associated with HDAC3 in vivo. J. Biol. Chem. 2001, 20, 35826-35835.
17. Jung, M.; Brosch, G.; Kölle, D.; Scherf, H.; Gerhäuser, C.; et al. Amide analogues of trichostatin A as inhibitors of histone deacetylase and inducers of terminal cell differentiation. J. Med. Chem. 1999, 42, 4669-4679.
18. Furumai, R.; Komatsu, Y.; Nishino, N.; Khochbin, S.; Yoshida, M.; et al. Potent histone deacetylase inhibitors built from trichostatin A and cyclic tetrapeptide antibiotics including trapoxin. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 87-92.
19. Yoshida, M.; Furumai, R.; Komatsu, Y.; Nishino, N.; Horinouchi, S. Histone deacetylase as a new target for cancer chemotherapy. Cancer Chemother. Pharmacol. 2001, 48 (Suppl. 1), S20-S26.
20. Wang, D. F.; Wiest, O.; Helquist, P.; Lan-Hargest, H. Y.; Wiech, N. L. On the function of the 14 A long internal cavity of histone deacetylase-like protein: Implications for the design of histone deacetylase inhibitors. J. Med. Chem. 2004, 47, 3409-3417.
21. Bouchain, G.; Delorme, D. Novel hydroxamate and anilide derivatives as potent histone deacetylase inhibitors: Synthesis and antiproliferative evaluation. Curr. Med. Chem. 2003, 10, 2359-2372.
22. Jaboin, J.; Wild, J.; Hamidi, H.; Khanna, C.; Kim, C. J.; et al. MS-27-275, an inhibitor of histone deacetylase, has marked in vitro and in vivo antitumor activity against pediatric solid tumors. Cancer Res. 2002, 62, 6108-6115.
23. Saito, A.; Yamashita, T.; Mariko, Y.; Nosaka, Y.; Tsuchiya, K.; et al. A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 4592-4597.
24. Suzuki, T.; Ando, T.; Tsuchiya, K.; Fukazawa, N.; Saito, A.; et al. Synthesis and histone deacetylase inhibitory activity of new benzamide derivatives. J. Med. Chem. 1999, 42, 3001-3003.
25. Wong, J. C.; Hong, R.; Schreiber, S. L. Structural biasing elements for in-cell histone deacetylase paralog selectivity. J. Am. Chem. Soc. 2003, 125, 5586-5587.
26. Fournel, M.; Trachy-Bourget, M. C.; Yan, P. T.; Kalita, A.; Bonfils, C.; et al. Sulfonamide anilides, a novel class of histone deacetylase inhibitors, are antiproliferative against human tumors. Cancer Res. 2002, 62, 4325-4330.
27. Kraker, A. J.; Mizzen, C. A.; Hartl, B. G.; Miin, J.; Allis, C. D.; et al. Modulation of histone acetylation by [4-(acetylamino)-N-(2-amino-phenyl) benzamide] in HCT-8 colon carcinoma. Mol. Cancer Ther. 2003, 2, 401-408.
28. Haggarty, S. J.; Koeller, K. M.; Wong, J. C.; Grozinger, C. M.; Schreiber, S. L. Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 4389-4394.
29. Cao, H.; Stamatoyannopoulos, G.; Jung, M. Induction of human gamma globin gene expression by histone deacetylase inhibitors. Blood 2004, 103, 701-709.
30. Hoffmann, K.; Brosch, G.; Loidl, P.; Jung, M. First nonradioactive assay for in vitro screening of histone deacetylase inhibitors. Pharmazie 2000, 55, 601-606.
31. Jung, M.; Hoffmann, K.; Brosch, G.; Loidl, P. Analogues of trichostatin A and trapoxin B as histone deacetylase inhibitors. Bioorg. Med. Chem. Lett. 1997, 7, 1655-1658.
32. Schmidt, K.; Gust, R.; Jung, M. Inhibitors of histone deacetylase suppress the growth of MCF-7 breast cancer cells. Arch. Pharm. Pharm. Med. Chem. 1999, 332, 353-357.
33. Jackson, M. D.; Denu, J. M. Structural identification of 2′- and 3′-O-acetyl-ADP-ribose as novel metabolites derived from the Sir2 family of beta-NAD+-dependent histone/protein deacetylases. J. Biol. Chem. 2002, 277, 18535-18544.
34. Fischle, W.; Emiliani, S.; Hendzel, M. J.; Nagase, T.; Nomura, N.; et al. A new family of human histone deacetylases related to saccharomyces cerevisiae HDA1p. J. Biol. Chem. 1999, 274, 11713-11720.
35. Fischle, W.; Dequiedt, F.; Hendzel, M. J.; Guenther, M. G.; Lazar, M. A.; et al. Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. Mol. Cell 2002, 9, 45-57.